bpc-157 regulatory status fda Peptide Reclassification 2026: What It Means for Providers FDA's Overreach on Compounded Peptides
Description
It appears on the FDAs list of certain bulk drug substances that may present significant safety risks in compounding contexts
A combination of omega-3 fatty acids, folic acid and B-group vitamins is superior at lowering homocysteine than omega-3 alone: A meta-analysis
Cyanocobalamin, a slightly toxic, synthetic form, is especially dangerous to pernicious anemia patients
Patients experiencing right upper quadrant pain, particularly if accompanied by fever or jaundice, should be evaluated for gallbladder disease
Our providers at each of our locations are accepting new patients
